Home/Filings/4/0001628280-23-036052
4//SEC Filing

DE GREEF RODERICK 4

Accession 0001628280-23-036052

CIK 0000834365other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 5:29 PM ET

Size

7.5 KB

Accession

0001628280-23-036052

Insider Transaction Report

Form 4
Period: 2023-10-19
Transactions
  • Award

    Common Stock

    2023-10-19+394,856442,539 total
  • Award

    Restricted Stock Award

    2023-10-19+394,856394,856 total
    Exercise: $0.00Common Stock (394,856 underlying)
Footnotes (3)
  • [F1]The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of their employment agreement.
  • [F2]This reflects the total amount beneficially owned by the reporting person as of October 19, 2023. Previous Form 4's filed by the reporting person before October 19, 2023 did not reflect the acquisition of 2,421 shares.
  • [F3]The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027.

Issuer

BIOLIFE SOLUTIONS INC

CIK 0000834365

Entity typeother

Related Parties

1
  • filerCIK 0001241181

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 5:29 PM ET
Size
7.5 KB